These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8637631

  • 1. Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum.
    Levivier M, Gash DM, Przedborski S.
    Neuroscience; 1995 Nov; 69(1):43-50. PubMed ID: 8637631
    [Abstract] [Full Text] [Related]

  • 2. Quinolinic acid-induced lesions of the rat striatum: quantitative autoradiographic binding assessment.
    Levivier M, Przedborski S.
    Neurol Res; 1998 Jan; 20(1):46-56. PubMed ID: 9471103
    [Abstract] [Full Text] [Related]

  • 3. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, Poewe W, Wenning GK.
    Neuroscience; 2000 Jan; 95(2):377-88. PubMed ID: 10658617
    [Abstract] [Full Text] [Related]

  • 4. Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABA(A) receptor changes.
    Brickell KL, Nicholson LF, Waldvogel HJ, Faull RL.
    J Chem Neuroanat; 1999 Oct; 17(2):75-97. PubMed ID: 10585160
    [Abstract] [Full Text] [Related]

  • 5. Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy).
    Puschban Z, Waldner R, Seppi K, Stefanova N, Humpel C, Scherfler C, Levivier M, Poewe W, Wenning GK.
    Exp Neurol; 2000 Jul; 164(1):166-75. PubMed ID: 10877927
    [Abstract] [Full Text] [Related]

  • 6. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM, Cherry SR, Tatsukawa KJ, Toyokuni T, Kornblum HI.
    Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
    [Abstract] [Full Text] [Related]

  • 7. Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: comparison with the dopamine receptor imaging.
    Ishiwata K, Ogi N, Hayakawa N, Oda K, Nagaoka T, Toyama H, Suzuki F, Endo K, Tanaka A, Senda M.
    Ann Nucl Med; 2002 Nov; 16(7):467-75. PubMed ID: 12508837
    [Abstract] [Full Text] [Related]

  • 8. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration.
    Bazzett TJ, Becker JB, Kaatz KW, Albin RL.
    Exp Neurol; 1993 Apr; 120(2):177-85. PubMed ID: 8387931
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Protective effect of intrastriatal grafts in an experimental model of Huntington's disease. Behavioral and morphological correlation].
    Levivier M, Pearlman SH, Gash DM, Brotchi J.
    Neurochirurgie; 1991 Apr; 37(3):148-59. PubMed ID: 1831884
    [Abstract] [Full Text] [Related]

  • 11. Tyrosine hydroxylase-positive fibers and neurons in transplanted striatal tissue in rats with quinolinic acid lesions of the striatum.
    Sanberg PR, Zubrycki E, Ragozzino ME, Giordano M, Shipley MT.
    Brain Res Bull; 1990 Dec; 25(6):889-94. PubMed ID: 1981175
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sham transplantation protects against 6-hydroxydopamine-induced dopaminergic toxicity in rats: behavioral and morphological evidence.
    Przedborski S, Levivier M, Kostic V, Jackson-Lewis V, Dollison A, Gash DM, Fahn S, Cadet JL.
    Brain Res; 1991 Jun 07; 550(2):231-8. PubMed ID: 1832076
    [Abstract] [Full Text] [Related]

  • 14. Striatal grafts provide sustained protection from kainic and quinolinic acid-induced damage.
    Tulipan N, Luo SQ, Allen GS, Whetsell WO.
    Exp Neurol; 1988 Dec 07; 102(3):325-32. PubMed ID: 2973990
    [Abstract] [Full Text] [Related]

  • 15. Striatal implants of fetal striatum or gelfoam protect against quinolinic acid lesions of the striatum.
    Pearlman S, Levivier M, Gash DM.
    Brain Res; 1993 Jun 11; 613(2):203-11. PubMed ID: 8186968
    [Abstract] [Full Text] [Related]

  • 16. Female rats are more sensitive to the locomotor alterations following quinolinic acid-induced striatal lesions: effects of striatal transplants.
    Emerich DF, Zubricki EM, Shipley MT, Norman AB, Sanberg PR.
    Exp Neurol; 1991 Mar 11; 111(3):369-78. PubMed ID: 1847880
    [Abstract] [Full Text] [Related]

  • 17. Quantitative assessment of quinolinic acid-induced striatal toxicity in rats using radioligand binding assays.
    Levivier M, Holemans S, Togasaki DM, Maloteaux JM, Brotchi J, Przedborski S.
    Neurol Res; 1994 Jun 11; 16(3):194-200. PubMed ID: 7936089
    [Abstract] [Full Text] [Related]

  • 18. Metabolic changes after injection of quinolinic acid or 6-hydroxydopamine in the rat striatum: a time-course study using cytochrome oxidase and glycogene phosphorylase a histochemistry.
    Levivier M, Donaldson D.
    Neurol Res; 2000 Jun 11; 22(4):425-9. PubMed ID: 10874695
    [Abstract] [Full Text] [Related]

  • 19. Neural grafts and pharmacological intervention in a model of Huntington's disease.
    Giordano M, Ford LM, Shipley MT, Sanberg PR.
    Brain Res Bull; 1990 Sep 11; 25(3):453-65. PubMed ID: 1963345
    [Abstract] [Full Text] [Related]

  • 20. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.
    Shear DA, Dong J, Gundy CD, Haik-Creguer KL, Dunbar GL.
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct 11; 22(7):1217-40. PubMed ID: 9829299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.